You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY20 is not expected to be complete until September, 2021.
-
Biomaterials for mRNA based cellular reprogramming
SBC: Stem Pharm, Incorporated Topic: 100Project Summary Abstract Induced pluripotent stem cells iPSCs hold great promise in the areas of disease modeling and regenerative medicine and as a result have unique commercial potential There are currently more than ongoing clinical trials in stem cell therapies including the first in human trial using human iPSC derived retinal pigment epithelial cells to treat ...
SBIR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
Bioabsorbable Magnesium (Mg) Implants for Craniomaxillofacial Surgical Systems
SBC: NANOMAG LLC Topic: NIDCRProject Summary Abstract IntroductionnanoMAG LLCan engineered biomaterials manufactureris developing and commercializing next generationmagnesiumMgbiocompatible materials with applications in craniofacial and orthopaedic medicineThe overall goal of this SBIR Fast Track project is to develop a bioabsorbable Mg implant for mechanical fixation in craniofacial surgical proceduresThis will include conf ...
SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health -
Development of MTX for the Treatment of KRAS Mutant Colorectal Cancer
SBC: Mekanistic Therapeutics, LLC Topic: NCIPROJECT SUMMARY Mekanistic Therapeutics seeks to design discover and develop anti cancer agents that selectively inhibit multiple oncogenic pathways Its lead agent MTX was discovered in collaboration with the Leopold laboratory at University of Michigan MTX is a novel kinase inhibitor showing early promise for its therapeutic potential against solid cancers refractory to current treatm ...
STTR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
Commercial Software Using High throughput Computational Techniques to Improve Genome Analysis
SBC: Genomenon, Inc. Topic: 172Recent advances in DNA sequencing technology have not been matched by improved analytic techniques to quickly and accurately interpret patient genome data to inform diagnosis prognosis and therapy making decisions in the clinic and to identify candidate biomarkers of disease in research laboratories Development of automated techniques to facilitate interpretation of this data will benefit patien ...
SBIR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
A nanoparticle delivery system for CRISPR Cas based therapeutics
SBC: ATGC Inc. Topic: NCATSAbstract Applications of customizable nucleases such as CRISPR clustered regularly interspaced short palindromic repeats Cas CRISPR associated protein have enabled efficient and precise gene correction in vitro and hold promises for eventually achieving in vivo gene correction therapy However to apply CRISPR Cas in therapeutic settings several major challenges remain to be addressed ...
STTR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
HTS Assays for Targeting the cGAS STING Pathway in Autoimmune Diseases and Cancer
SBC: Bellbrook Labs, LLC Topic: 300SUMMARY Cytoplasmic nucleic acids alert the immune system to invading pathogens and trigger a robust type I interferon IFN response via activation of the STING stimulator of interferon genes receptor The sensor for cytoplasmic nucleic acids was recently discovered to be a cyclic GMP AMP synthase which produces a unique cyclic dinucleotide second messenger cGAMP that serves as an agonist fo ...
SBIR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
High Fidelity Linear MicroVector to Clone Complex Problematic and Large DNAs
SBC: VARIGEN BIOSCIENCES CORPORATION Topic: 200The goal of this research is to dramatically improve the ability to clone and analyze large and unstable DNA fragments We propose to develop a novel linear cloning vector to maximize stability of cloned DNA in the bacterial host The vector will use the replication proteins of the phage Phi to achieve the highest accuracy of replication for all DNA inserts including AT rich repetitive or str ...
SBIR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
Automation of MicroC as a CDx for myeloma therapies
SBC: Lynx Biosciences, Inc. Topic: 102Multiple myeloma MM is a debilitating and currently incurable hematological malignancy While the median survival has increased to years MM patients ultimately relapse and become resistant to therapy Once they reach this stage it is often a trial and error process until an effective therapy can be found Furthermore the MM bone marrow tumor microenvironment plays a significant role in ...
SBIR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
IMMEDIATE FIT USING INNOVATIVE TECHNOLOGY PROSTHETIC SYSTEMS
SBC: IFIT PROSTHETICS, LLC Topic: NABSTRACT The principal business interestiFIT Prosthetics LLCwith STTR fundingcreated a new transtibial prosthetic device and demonstrated its safetycomfortand functionIn contrast to conventionally made prosthetic limbsthe iFIT prosthesis is easily fit and aligned on the residual limb in a single sessionDue to its substantial adjustability and customized inner linerthe iFIT device is a comfortable ...
SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health -
Backyard Brains: Bringing Neurophysiology Into Secondary Schools
SBC: BACKYARD BRAINS INCORPORATED Topic: 101Project SummaryDecipheringhowthebrainfunctionsremainsoneofthegreatchallengesremainingtohumanityintriguingscientific professionals and the public equallyThe notorious complexity of the nervous system results in neuraldiseases remaining widespread and difficult to treatTools for studying the brain are often difficult to use andonlyavailabletograduatestudentsandscientistsinlargeresearchuniversitiesPr ...
SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health